(Q77093716)

English

An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group

scientific article published on 01 July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

179

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

S2-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Oral contraceptives and cycle control: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Desogestrel, norgestimate, and gestodene: the newer progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Long-term experience with a low-dose oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Evaluation and therapy of breakthrough bleeding in women using a triphasic oral contraceptive.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970290-X

7 January 2021

Identifiers

10.1016/S0002-9378(98)70290-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9704812%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77093716&oldid=1946581490"